|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Receivable related to potential business combination | ||||||||||||||||||||
| Extension contribution due from related parties | ||||||||||||||||||||
| Due from Tactical | ||||||||||||||||||||
| Due from Merger Co | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Cash held in Trust Account | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Total accounts payable | ||||||||||||||||||||
| Accrued expenses - related party | ||||||||||||||||||||
| Accounts payable - related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Promissory note - related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total promissory note - related party | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||||
| Deferred underwriting fee payable | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Class A ordinary shares subject to possible redemption, 42,486 shares at redemption value of approximately $11.72 and $11.64 per share at March 31, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Class A Ordinary Shares | ||||||||||||||||||||
| Total class A ordinary shares subject to possible redemption, 42,486 shares at redemption value of approximately $11.72 and $11.64 per share at March 31, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Shareholders’ Deficit | ||||||||||||||||||||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | ||||||||||||||||||||
| Ordinary shares, value | ||||||||||||||||||||
| Class A Ordinary Shares | ||||||||||||||||||||
| Class B Ordinary Shares | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Shareholders’ Deficit | ||||||||||||||||||||
| Total Shareholders’ Deficit | ||||||||||||||||||||
| Total Liabilities and Shareholders’ Deficit | ||||||||||||||||||||
Loading...
